MCK
McKesson's fourth quarter fiscal 2026 EPS of $11.69 beat estimates, driven by strong growth in its Oncology segment.
McKesson reported fourth quarter fiscal 2026 revenues of $96.3 billion, a 6% increase year-over-year, with adjusted EPS growing 16% to $11.69. For the full...
